Spark therapeutics, one of our competitors on mult
Post# of 30028
(Total Views: 584)
Posted On: 02/25/2019 10:02:00 AM
.jpg)
Spark therapeutics, one of our competitors on multiple fronts, but specifically retinitis pigmentosa, just got bought for $5b, by roche. They've got a whole host of general therapy tech. M&A is hot right now, and China agreement should keep the market for IPOs healthy.
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼